Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients

Abstract Background While immune checkpoint blockade has greatly improved clinical outcomes in diseases such as melanoma, there remains a need for predictive biomarkers to determine who will likely benefit most from which therapy. To date, most biomarkers of response have been identified in the tumo...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Priyanka B. Subrahmanyam, Zhiwan Dong, Daniel Gusenleitner, Anita Giobbie-Hurder, Mariano Severgnini, Jun Zhou, Michael Manos, Lauren M. Eastman, Holden T. Maecker, F. Stephen Hodi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2018-03-01
coleção:	Journal for ImmunoTherapy of Cancer
Acesso em linha:	http://link.springer.com/article/10.1186/s40425-018-0328-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!